Keywords: access, licenses, mugard, milestone, biosci, pharmaceuticals, signed

Access licenses MuGard to Milestone Biosci

Article | 01 September 2008

Access Pharmaceuticals has signed a definitive license agreement under which fellow USA-based Milestone Biosciences will market MuGard in the USA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing